Polygenic Risk Scores
Our genes provide valuable insight into our family history, our ancestry, and our health. As we learn more about our DNA, we identify new opportunities for healthcare. One such opportunity comes from using polygenic risk scores. In this video, you will learn what a polygenic risk score is, see how they can be used in healthcare, and find out how you can participate in research studies that use them.
Open Science accelerating identification of novel targets for therapeutics – Dr Wen Hwa Lee
Speaker: Dr Wen Hwa Lee – Director of the Disease Foundations Network programme – Open Science accelerating identification of novel targets for therapeutics at the Structural Genomics Consortium. From the Precision Medicine and Digital Health Technology Showcase on 27/6/17 at the Said Business School, Oxford.
Power in your pocket: real time DNA information – Dr Gordon Sanghera
Dr Gordon Sanghera, CEO, Oxford Nanopore Technologies, on the subject of taking real time DNA information out of the lab
towards the point of care. From the Precision Medicine and Digital Health Technology Showcase on 27/6/17 at the Said Business School, Oxford.
Genomics, big data and better health – Professor Michael Simpson
Speaker: Professor Michael Simpson, Co Head of Science at Genomics Plc, discusses genomics, big data and better health. From the Precision Medicine and Digital Health Technology Showcase on 27/6/17 at the Said Business School, Oxford.
Your genes and your heart – Hugh Watkins Open Weeks 2015
Hugh Watkins, at the Radcliffe Department of Medicine, University of Oxford, discussions the way that looking at genes helps with diagnosis and treatment of people with heart conditions. Talk given at the Oxford BRC Open Evening, 12th March 2015.
The 100,000 Genomes Project – Prof. A.Schuh
Professor Anna Schuh, Director of the Oxford NHS Genomic Medicine Centre and Associate Professor of Molecular Diagnostics for the University of Oxford's Department of Oncology, on Oxford’s role in the national 100,000 Genomes Project, a project to unravel the genetic changes underlying rare disease and cancers.
The project will aid research, improve diagnosis and ultimately clinical outcomes so NHS patients can receive care based on cutting edge scientific techniques. Eligible patients with rare diseases and cancers are being invited to provide health data and blood and tissue samples for whole genome sequencing, where a complete set of a person's genes is decoded.
From Genes to Brains – Liz Tunbridge
Presentation by Elizabeth Tunbridge, Associate Professor, Department of Psychiatry, University of Oxford. Liz Tunbridge describes the potential of genetic studies to enhance our understanding of mental health conditions.
Tackling and tracking TB through DNA analysis
Find out how a multidisciplinary team of scientists came to create England's new way to identify how to fight and track TB outbreaks using DNA analysis.
http://modmedmicro.nsms.ox.ac.uk